熊 波 蔡 琳 陳應(yīng)忠 周名綱 丁尋實(shí) 夏 蘢(成都市第三人民醫(yī)院心血管內(nèi)科 成都 610031)
胱抑素C及同型半胱氨酸與冠心病病變程度相關(guān)性研究
熊波蔡琳陳應(yīng)忠周名綱丁尋實(shí)夏蘢(成都市第三人民醫(yī)院心血管內(nèi)科成都610031)
摘要:目的:觀(guān)察不同病變程度的冠心病患者血漿胱抑素C(Cyst C)和同型半胱氨酸(HCY)水平,研究Cyst C及HCY水平與冠脈狹窄病變的臨床關(guān)系。方法:選取2015年9月~2016年2月我院心內(nèi)科收治的冠心病患者134例。根據(jù)冠脈造影結(jié)果分為單支病變組45例、雙支病變組40例和三支病變組49例。根據(jù)冠狀動(dòng)脈Gensini評(píng)分結(jié)果分為輕度狹窄組44例、中度狹窄組46例和重度狹窄組44例。同時(shí)選擇疑似冠心病患者42例為對(duì)照組。分別用ELISA法和高效液相色譜法(High Performance Liquid Chromatography)檢測(cè)各組受試者血漿中的Cyst C和HCY濃度,并應(yīng)用Pearson進(jìn)行分析。結(jié)果:隨著冠脈病變支數(shù)的增加和病變狹窄程度的加重,患者的血漿Csyt C和HCY水平均增高(P<0.05)。三支病變組、雙支病變組、單支病變組之間血漿Csyt C和HCY水平存在差異(P<0.05);重度狹窄組、中度狹窄組、輕度狹窄組之間血漿Csyt C和HCY水平同樣存在差異(P<0.05)?;颊叩难獫{Cyst C 和HCY水平均與冠脈Gensini積分呈正相關(guān)(r=0.514,0.476,P<0.01),血漿Cyst C與HCY水平呈顯著性正相關(guān)(r=0.743,P<0.01)。結(jié)論:冠心病患者血漿Cyst C和HCY水平升高,且隨著冠脈病變支數(shù)的增加及病變狹窄程度的加重而逐漸增高,同時(shí)與冠狀動(dòng)脈Gensini評(píng)分正相關(guān)。因此臨床上聯(lián)合檢測(cè)患者血漿Cyst C及HCY水平對(duì)于冠狀動(dòng)脈狹窄病變程度有一定的初步預(yù)測(cè)價(jià)值。
關(guān)鍵詞:胱抑素C同型半胱氨酸 冠心病 Gensini評(píng)分
動(dòng)脈粥樣硬化和粥樣斑塊是冠心病的主要病理表現(xiàn),具體發(fā)生機(jī)制尚不完全明確。近年來(lái)研究表明,Cyst C和HCY可能參與炎癥反應(yīng)和動(dòng)脈粥樣硬化斑塊的形成,與心血管疾病的發(fā)生發(fā)展密切相關(guān)[1]。本文收集134例冠狀動(dòng)脈造影患者的臨床資料,評(píng)價(jià)Cyst C及HCY與冠脈病變及其嚴(yán)重程度是否相關(guān),探討聯(lián)合檢測(cè)Cyst C及HCY水平對(duì)于預(yù)測(cè)冠脈病變程度的臨床價(jià)值。
1.1一般資料:選取成都市第三人民醫(yī)院心內(nèi)科2015年9月~2016年2月住院的冠心病患者(以第9版Braunwald《心臟病學(xué)》制定的診斷標(biāo)準(zhǔn))134例,并經(jīng)冠狀動(dòng)脈造影(CAG)證實(shí)至少有一支冠狀動(dòng)脈(左主干、左前降支、左回旋支、右冠狀動(dòng)脈)及其主要分支動(dòng)脈血管內(nèi)徑狹窄≥50%。其中男性82例,女性52例,平均年齡(59.45±9.45)歲。根據(jù)冠狀動(dòng)脈病變累及支數(shù)分為單支病變組(45例)、雙支病變組(40例)及三支病變組(49例)。根據(jù)美國(guó)心臟病協(xié)會(huì)(AHA)規(guī)定的改良Gensini積分系統(tǒng)[2]對(duì)每支病變血管狹窄程度進(jìn)行定量評(píng)分。按Gensini積分情況分為三組,即輕度狹窄組(積分<30分)44例、中度狹窄組(積分30~90分)46例、重度狹窄組(積分>90分)44例。選取42例CAG檢查證實(shí)冠狀動(dòng)脈<50%狹窄的疑似冠心病患者為對(duì)照組,其中男性28例,女性14例,平均年齡(57.32±8.41)歲。所有受試者簽署知情同意書(shū),并經(jīng)醫(yī)院倫理委員會(huì)批準(zhǔn)。并排除風(fēng)濕性心臟病、肺源性心臟病等其他心血管?。粐?yán)重肝腎功能不全者;妊娠、哺乳期婦女及合并有急慢感染病史、惡性腫瘤等;近6個(gè)月有手術(shù)等。
1.2檢測(cè)方法:應(yīng)用ELISA雙抗體夾心法檢測(cè)血漿Cyst C水平,高效液相色譜法檢測(cè)血漿HCY水平。
1.2.1檢測(cè)Cyst C(雙抗體夾心法):①取5mL空腹靜脈血注入EDTA抗凝管,以3000r/min離心15min分離血漿,置于-80℃冰箱。②稀釋與加樣標(biāo)準(zhǔn)品、置37℃溫育30min、每個(gè)孔加入酶標(biāo)試劑50μL,空白孔除外。③37℃溫育30min、每個(gè)孔先加入顯色劑A50μL,再加入顯色劑B50μL,震蕩混勻,37℃避光顯色15 min。④每個(gè)孔加入終止液50μL,450nm波長(zhǎng)依序測(cè)量各孔的OD值并計(jì)算。
1.2.2檢測(cè)HCY(高效液相色譜法測(cè)定):①采集抗凝血液,分離出血漿;②將含有硼氫化鈉、二甲基亞砜和氫氧化鈉的溶液,含有EDTA和二巰基蘇糖醇的溶液,以1-辛醇、鹽酸溶液共同加入標(biāo)本,室溫下混勻,靜置1min;③加入含有衍生化試劑bromobimane的緩沖液,混勻1min后進(jìn)樣;④色譜柱采用150mm× 4.6mm的反相C18柱,進(jìn)樣前采用pH3.6的硝酸銨和甲酸銨緩沖液平衡,然后用乙腈進(jìn)行梯度洗脫,半胱氨酸和同型半胱氨酸的保留時(shí)間分別為3.76min、4.14min。
1.3統(tǒng)計(jì)學(xué)方法:應(yīng)用SPSS17.0統(tǒng)計(jì)學(xué)軟件進(jìn)行數(shù)據(jù)分析,計(jì)量資料以均數(shù)±標(biāo)準(zhǔn)差(±s)表示,兩組間比較采用t檢驗(yàn),以P<0.05表示差異具有統(tǒng)計(jì)學(xué)意義。相關(guān)分析應(yīng)用Pearson分析其相關(guān)性。
2.1不同病變支數(shù)冠心病病例血漿Cyst C和HCY水平比較:?jiǎn)沃Р∽兘M、雙支病變組和三支病變組的血漿Cyst C和HCY水平均高于對(duì)照組,差異具有統(tǒng)計(jì)學(xué)意義(P<0.05)。三支病變組血漿Cyst C和HCY的濃度高于雙支病變組和單支病變組(P<0.05);雙支病變組血漿Cyst C和HCY的濃度均高于單支病變組,差異具有統(tǒng)計(jì)學(xué)意義(P<0.05),見(jiàn)表1。

表1不同病變支數(shù)冠心病病例Cyst C和HCY水平比較
2.2冠脈不同狹窄程度組血漿Cyst C和HCY水平比較:各冠脈不同狹窄程度組血漿的Csyt C和HCY水平均高于對(duì)照組,隨著冠脈狹窄程度的增加,Csyt C和HCY水平逐漸增高,任一組間比較差異均有統(tǒng)計(jì)學(xué)意義(P<0.05),見(jiàn)表2。

表2不同Gensini積分組Cyst C和HCY水平比較
2.3冠心病患者Cyst C和HCY水平與冠脈Gensi-ni積分的相關(guān)性:通過(guò)Pearson相關(guān)分析顯示,Cyst C水平與冠脈Gensini積分呈正相關(guān)(r=0.521,P<0.01),HCY水平與冠脈Gensini積分呈正相關(guān)(r=0.486,P<0.01)。
2.4血漿Cyst C水平與HCY水平的相關(guān)性分析:經(jīng)線(xiàn)性相關(guān)分析冠心病患者血漿Cyst C水平與HCY水平呈顯著性正相關(guān)(r= 0.724,P<0.01)。
Cyst C主要來(lái)源于機(jī)體有核細(xì)胞中,無(wú)組織特異性,可持續(xù)、恒定地表達(dá)[3]。早期大量臨床及實(shí)驗(yàn)室研究表明,Cyst C和HCY通過(guò)以下途徑參與動(dòng)脈粥樣硬化的各個(gè)環(huán)節(jié):①參與調(diào)控細(xì)胞內(nèi)外蛋白質(zhì)的分解,可引起細(xì)胞外基質(zhì)和內(nèi)彈性膜的降解增多,侵入內(nèi)膜的單核巨噬細(xì)胞和血管平滑肌增多[4];②可影響脂質(zhì)代謝;③還通過(guò)參與炎癥反應(yīng)、影響中性粒細(xì)胞的遷移,增強(qiáng)中性粒細(xì)胞的趨化和吞噬能力,間接影響血管壁、細(xì)胞外基質(zhì)生成和降解的平衡過(guò)程[5~6];④直接損傷血管內(nèi)皮細(xì)胞,從而啟動(dòng)血管內(nèi)膜的炎癥-纖維增生性反應(yīng)[7~8]。而Cyst C是半胱氨酸蛋白酶抑制劑超家族成員之一,可通過(guò)抑制半胱氨酸蛋白酶活性,減少HCY的分解,從而導(dǎo)致HCY過(guò)度表達(dá)和蓄積在動(dòng)脈內(nèi)膜損傷處[9~10],因此Cyst C和HCY兩者之間存在密切的聯(lián)系。本次研究也證實(shí)冠心病組血漿Cyst C水平與HCY水平呈顯著性正相關(guān)。
本次研究結(jié)果可見(jiàn),冠心病患者不同病變冠脈支數(shù)組Cyst C和HCY濃度明顯增加,且隨著病變冠脈支數(shù)增加和冠脈狹窄程度加重,Cyst C和HCY水平逐漸升高,證實(shí)Cyst C和HCY與冠心病的發(fā)生、發(fā)展過(guò)程均有密切聯(lián)系。因此,聯(lián)合檢測(cè)血漿Cyst C及HCY水平對(duì)于初步預(yù)測(cè)冠狀動(dòng)脈狹窄病變程度具有一定的臨床價(jià)值,可增加樣本量進(jìn)一步研究血漿中Cyst C及HCY水平與冠心病的關(guān)系。另一方面,血漿Cyst C和HCY水平雖然與冠心病有著密切的聯(lián)系,但Cyst C及HCY水平是作為冠心病的致病因子還是冠心病發(fā)生的一種伴隨現(xiàn)象,還需深入研究。
綜上所述,冠心病患者血漿Cyst C和HCY水平明顯升高,隨著病變支數(shù)的增加及狹窄病變程度而逐漸升高,聯(lián)合檢測(cè)血漿Cyst C及HCY水平可初步預(yù)測(cè)冠狀動(dòng)脈狹窄病變程度。
參考文獻(xiàn)
[1]ARPEGARD J,OSTERGREN J,DEFAIRE U,Cystatin C a marker of peripheral at cherosclerotic disease[J].Atherosclerosis,2008,199:397-401.
[2]Gensini GG.A more meaningful scoring system for determining the severity of coronary heart disease[J].Am J Cardiol,1983,51 (3):606.
[3]Takeyabu K,Betsuyaku T,Nishimura M,et al.Cysteine proteinases and Cystatin C in bronchoalveolar lavage fluid from subjects with subclinical emphysema.Eur Respir J,1998,12(2):1033-1039.
[4]Wang B,Sun J,Kitamoto S,et al.Cathepsin S controls angiogenesis and tumor growth via matrik-derived angiogenic factors[J].J Biol Chem,2006,281(9):6020.
[5]Shi GP,Sukhova GK,Grubb A,et al.Cystatin C deliciency in human athero sclerosis and aortic aneurysms[J].J C lin Invest,1999,104:1191.
[6]SCHULTE S,SUN J,LIBBY P,et al.Cystatin C deficiency promotes inflammation in angiotensin II-induced abdominal aortic aneurisms in atherosclerotic mice[J].Am I Pathol,2010,177:456-463.
[7]Weiss N,Zhang YY,Heydricks S,et al.Overexpression of cellular glutathione peroxidase rescues homocyst(e)ine-induced endothelial dysfunction[J].Proc Natl Acad Sci USA,2001,98:12503-12508.
[8]張輝,黨瑜華,張菲斐.金屬硫蛋白和同型半胱氨酸對(duì)人臍靜脈內(nèi)皮細(xì)胞PAI-1活性及mRNA表達(dá)的影響[J].鄭州大學(xué)學(xué)報(bào)(醫(yī)學(xué)版),2004,39(5):476-478.
[9]唐燕,李瑞瑞,姚恩生.血清同型半胱氨酸、胱抑素C與高血壓頸動(dòng)脈粥樣硬化的關(guān)系[J].農(nóng)墾醫(yī)學(xué),2012,34(1):23-25.
[10]丁東,李維春,張克昌.胱抑素C在急性冠脈綜合征中的臨床價(jià)值[J].安徽衛(wèi)生職業(yè)技術(shù)學(xué)院學(xué)報(bào),2011,10(6):84-85.
中圖分類(lèi)號(hào):R541.4
文獻(xiàn)標(biāo)識(shí)碼:B
文章編號(hào):1672-8351(2016)07-0135-02
Abstract:Objective:To observe the plasmatic cystatin C(Cyst C)and homocysteine(HCY)levels of coronary artery disease(CHD)patients with different lesion extent,and explore the clinical predictive value of Cyst C and HCY on CHD lesions.Methods:134 patients in the department of Cardiology from September 2015 to February 2016 were selected.According to the results of coronary angiography,they were divided into single-vessellesion group(45 cases),double vessellesion group(40 cases),three-vessellesion group(49 cases). According to the results of coronary Gensini score,they were divided into mild stenosis group(44 cases),moderate stenosis group(46 cases),severe stenosis group(44 cases).42 CHD suspected cases were enrolled as the control group.The plasmatic cystatin C(Cyst C)and homocysteine(HCY)levels were measured by ELISA and HPLC,and their correlation was analyzed by Pearson.Results:The plasmatic Cyst C and HCY level of single-vessel lesion group,double-vessel lesion group and three-vessel lesion group were higher than the control group(P<0.05).three-vessel lesion group were higher than the two-vessel lesion group and single vessel lesion group (P<0.05),two-vessel lesion group was higher than the single vessel lesion group(P<0.05).The plasmatic Cyst C and HCY level of mild stenosis group,moderate stenosis group and severe stenosis group were higher than the control group(P<0.05).severe stenosis group were higher than mild stenosis group and moderate stenosis group(P<0.05),moderate stenosis group was higher than mild stenosis(P<0.05).the plasmatic cystatin C(Cyst C)and homocysteine(HCY)levels were positively correlated with coronary Gensini score(r= 0.514,0.476,P<0.01),plasma Cyst C and HCY levels were positively correlated(r=0.743,P<0.01).Conclusions:Plasmatic Cyst C and HCY levels in patients with coronary heart disease increased significantly,they could increase gradually with the increase of lesion vesseland stenosis,and they were positively correlated with coronary Gensini score.Combined detection of plasmatic Cyst C and HCY levels can predict the lesion extent of coronary artery stenosis.
Key words:Cystatin C Homocysteine Coronary heart disease Gensini score